Influence of endothelial nitric oxide synthase gene polymorphisms (- 786T > C, 4a4b, 894G > T) in Korean patients with coronary artery disease

Thrombosis Research

Volumn 119, Issue 5, 2007, Pages 579-585

  Kim, In Jai ^a,b   Bae, Jeehyeon ^c   Lim, Sang Wook ^b   Cha, Dong Hoon ^b   Cho, Hyo Jin ^a   Kim, Sun ^a   Yang, Dong Ho ^b   Hwang, Seong Gyu ^a,b   Oh, Doyeun ^a,b   Kim, Nam Keun ^a  

^a Bundang CHA Hospital   (South Korea)

^b CHA University   (South Korea)

^c CHA Bundang Medical Center   (South Korea)

Author keywords

Coronary artery disease; Endothelial nitric oxide synthase; Nitric oxide; Polymorphism

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLYCINE; THREONINE;

ADULT; ALLELE; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; FEMALE; GEL ELECTROPHORESIS; GENE DELETION; GENE INSERTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYPERTENSION; INTRON; KOREA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT; RISK ASSESSMENT; RISK FACTOR; SMOKING; STATISTICAL SIGNIFICANCE;

CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; GENOTYPE; HUMANS; KOREA; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 33847236166     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2006.06.005     Document Type: Article

References (41)

1. Kuvin J.T., Patel A.R., Sliney K.A., Pandian N.G., Rand W.M., Udelson J.E., et al. Peripheral vascular endothelial function testing as a noninvasive indicator of coronary artery disease. J Am Coll Cardiol 38 (2001) 1843-1849
2. Heitzer T., Schlinzig T., Krohn K., Meinertz T., and Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 104 (2001) 2673-2678
3. Faxon D.P., Fuster V., Libby P., Beckman J.A., Hiatt W.R., Thompson R.W., et al. American Heart Association. Atherosclerotic vascular disease conference: writing group III: pathophysiology. Circulation 109 (2004) 2617-2625
4. Puddu P., Cravero E., Puddu G.M., and Muscari A. Genes and atherosclerosis: at the origin of the predisposition. Int J Clin Pract 59 (2005) 462-472
5. Ohashi Y., Kawashima S., Hirata K., Yamashita T., Ishida T., Inoue N., et al. Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase. J Clin Invest 102 (1998) 2061-2071
6. Huang P.L., Huang Z., Mashimo H., Bloch K.D., Moskowitz M.A., Bevan J.A., et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377 (1995) 239-242
7. Wolf A., Zalpour C., Theilmeier G., Wang B.Y., Ma A., Anderson B., et al. Dietary l-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans. J Am Coll Cardiol 29 (1997) 479-485
8. Kubes P., Suzuki M., and Granger D.N. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci 88 (1991) 4651-4655
9. Garg U.C., and Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83 (1989) 1774-1777
10. Böger R.H., Bode-Böger S.M., Mügge A., Kienke S., Brandes R., Dwenger A., et al. Supplementation of hypercholesterolaemic rabbits with l-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis 117 (1995) 273-284
11. Hogg N., Kalyanaraman B., Joseph J., Struck A., and Parthasarathy S. Inhibition of low-density lipoprotein oxidation by nitric oxide. Potential role in atherogenesis. FEBS Lett 334 (1993) 170-174
12. Wilcox J.N., Subramanian R.R., Sundell C.L., Tracey W.R., Pollock J.S., Harrison D.G., et al. Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler Thromb Vasc Biol 17 (1997) 2479-2488
13. Janssens S.P., Shimouchi A., Quertermous T., Bloch D.B., and Bloch K.D. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem 267 (1992) 14519-14522
14. Tai S.C., Robb G.B., and Marsden P.A. Endothelial nitric oxide synthase: a new paradigm for gene regulation in the injured blood vessel. Arterioscler Thromb Vasc Biol 24 (2004) 405-412
15. Nakayama M., Yasue H., Yoshimura M., Shimasaki Y., Kugiyama K., Ogawa H., et al. T-786->C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99 (1999) 2864-2870
16. Yoshimura M., Yasue H., Nakayama M., Shimasaki Y., Sumida H., Sugiyama S., et al. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet 103 (1998) 65-69
17. Wang X.L., Sim A.S., Badenhop R.F., McCredie R.M., and Wilcken D.E. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 2 (1996) 41-45
18. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo Jr. J.L., et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289 (2003) 2560-2572
19. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 27 (2004) s5-s9
20. Asakimori Y., Yorioka N., Tanaka J., and Kohno N. Effect of polymophism of the nitric oxide synthase and apolipoprotein E genes on carotid atherosclerosis in hemodialysis patients. Am J Kidney Dis 41 (2003) 822-832
21. Fatini C., Sofi F., Sticchi E., Gensini F., Gori A.M., Fedi S., et al. Influence of endothelial nitric oxide synthase gene polymorphisms (894G > T, 4a4b, T-786C) and hyperhomocysteinemia on the predisposition to acute coronary syndromes. Am Heart J 147 (2004) 516-521
22. Hassan A., Gormley K., O'Sullivan M., Knight J., Sham P., Vallance P., et al. Endothelial nitric oxide gene haplotypes and risk of cerebral small-vessel disease. Stroke 35 (2004) 654-659
23. Colombo M.G., Paradossi U., Andreassi M.G., Botto N., Manfredi S., Masetti S., et al. Endothelial nitric oxide synthase gene polymorphisms and risk of coronary artery disease. Clin Chem 49 (2003) 389-395
24. Rossi G.P., Cesari M., Zanchetta M., Colonna S., Maiolino G., Pedon L., et al. The T-786C endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in Caucasian patients of the GENICA study. J Am Coll Cardiol 41 (2003) 930-937
25. Erbs S., Baither Y., Linke A., Adams V., Shu Y., Lenk K., et al. Promoter but not exon 7 polymorphism of endothelial nitric oxide synthase affects training-induced correction of endothelial dysfunction. Arterioscler Thromb Vasc Biol 23 (2003) 1814-1819
26. Ghilardi G., Biondi M.L., DeMonti M., Bernini M., Turri O., Massaro F., et al. Independent risk factor for moderate to severe internal carotid artery stenosis: T-786C mutation of the endothelial nitric oxide synthase gene. Clin Chem 48 (2002) 989-993
27. Alvarez R., Gonzalez P., Batalla A., Reguero J.R., Iglesias-Cubero G., Hevia S., et al. Association between the NOS3 (- 786T/C) and the ACE (I/D) DNA genotypes and early coronary artery disease. Nitric Oxide 5 (2001) 343-348
28. Fatini C., Sofi F., Gensini F., Sticchi E., Lari B., Pratesi G., et al. Influence of eNOS gene polymorphisms on carotid atherosclerosis. Eur J Vasc Endovasc Surg 27 (2004) 540-544
29. Fatini C., Sofi F., Sticchi E., Gensini F., Gori A.M., Fedi S., et al. Influence of endothelial nitric oxide synthase gene polymorphisms (894G > T, 4a4b, T-786C) and hyperhomocysteinemia on the predisposition to acute coronary syndromes. Am Heart J 147 (2004) 516-521
30. Wang X.L., Mahaney M.C., Sim A.S., Wang J., Wang J., Blangero J., et al. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol 17 (1997) 3147-3153
31. Ichihara S., Yamada Y., Fujimura T., Nakashima N., and Yokota M. Association of a polymorphism of the endothelial constitutive nitric oxide synthase gene with myocardial infarction in the Japanese population. Am J Cardiol 81 (1998) 83-86
32. Park J.E., Lee W.H., Hwang T.H., Chu J.A., Kim S., Choi Y.H., et al. Aging affects the association between endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction in the Korean male population. Korean J Intern Med 15 (2000) 65-70
33. Yoon Y., Song J., Hong S.H., and Kim J.Q. Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease. Clin Chem 46 (2000) 1626-1630
34. Granath B., Taylor R.R., van Bockxmeer F.M., and Mamotte C.D. Lack of evidence for association between endothelial nitric oxide synthase gene polymorphisms and coronary artery disease in the Australian Caucasian population. J Cardiovasc Risk 8 (2001) 235-241
35. Milutinovic A., and Hruskovicova H. The eNOS gene polymorphism does not have a major impact on lipid parameters and premature coronary artery disease in Slovene men (Caucasians). Folia Biol (Praha) 51 (2005) 47-49
36. Golser R., Gorren A.C., Mayer B., and Schmidt K. Functional characterization of Glu298Asp mutant human endothelial nitric oxide synthase purified from a yeast expression system. Nitric Oxide 8 (2003) 7-14
37. Hingorani A.D., Liang C.F., Fatibene J., Lyon A., Monteith S., Parsons A., et al. A common variant of the endothelial nitric oxide synthase (Glu298->Asp) is a major risk factor for coronary artery disease in the UK. Circulation 100 (1999) 1515-1520
38. McNamara D.M., Holubkov R., Postava L., Ramani R., Janosko K., Mathier M., et al. Effect of the Asp298 variant of endothelial nitric oxide synthase on survival for patients with congestive heart failure. Circulation 107 (2003) 1598-1602
39. Cam S.F., Sekuri C., Tengiz I., Ercan E., Sagcan A., Akin M., et al. The 894G > T polymorphism on endothelial nitric oxide synthase gene is associated with premature coronary artery disease in a Turkish population. Thromb Res 116 (2005) 287-292
40. Shimasaki Y., Yasue H., Yoshimura M., Nakayama M., Kugiyama K., Ogawa H., et al. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol 31 (1998) 1506-1510
41. Wang C.L., Hsu L.A., Ko Y.S., Ko Y.L., and Lee Y.H. Lack of association between the Glu298Asp variant of the endothelial nitric oxide synthase gene and the risk of coronary artery disease among Taiwanese. J Formos Med Assoc 100 (2001) 736-740